Prognostic impact of NPM1 and FLT3 mutations in AML, progression of monoclonal B cell lymphocytosis, and creating RBCs with rare blood types in the laboratory

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Armchair Anonymous: Bad Customer 54 min · 25 Sep 2026 · Armchair Expert with Dax Shepard

Headlines: Car crash kills junior police officer 4 min · 25 Sep 2026 · The Daily Aus

Day 268: Rebuilding the Temple (2026) 29 min · 25 Sep 2026 · The Bible in a Year (with Fr. Mike Schmitz)

NPR News: 09-25-2026 3AM EDT 5 min · 25 Sep 2026 · NPR News Now

ADHD Expert: Why You Feel Motivated But Can't Do Anything 1h 9m · 25 Sep 2026 · The Jefferson Fisher Podcast

3AM ET 09/25/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded13 Oct 2022

Publisherfeeds.transistor.fm ↗

Handlerec:11742064

Show notes

In this week’s episode we’ll learn more about the prognostic impact of NPM1 and FLT3 mutations in AML, discuss the progression and survival of monoclonal B-cell lymphocytosis, and learn more about the use of red blood cells derived from pluripotent stem cells in transfusion medicine.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in